Uniphar Resultados de beneficios anteriores
Pasado controles de criterios 2/6
Uniphar ha aumentado sus beneficios a una tasa media anual de 23.4%, mientras que los beneficios de la industria de Healthcare han experimentado un crecimiento de 8.4% anual. Los ingresos han ido creciendo a una tasa media de 9.8% al año. La rentabilidad financiera de Uniphar es de 13.5%, y sus márgenes netos son de 1.8%.
Información clave
23.4%
Tasa de crecimiento de los beneficios
11.2%
Tasa de crecimiento del BPA
Crecimiento de la industria Healthcare | 13.4% |
Tasa de crecimiento de los ingresos | 9.8% |
Rentabilidad financiera | 13.5% |
Margen neto | 1.8% |
Última actualización de beneficios | 31 Dec 2023 |
Actualizaciones de resultados anteriores recientes
Recent updates
Here's Why Shareholders May Want To Be Cautious With Increasing Uniphar plc's (ISE:UPR) CEO Pay Packet
May 03Is There An Opportunity With Uniphar plc's (ISE:UPR) 37% Undervaluation?
Apr 20Investors Met With Slowing Returns on Capital At Uniphar (ISE:UPR)
Jan 31Uniphar plc's (ISE:UPR) 25% Jump Shows Its Popularity With Investors
Dec 18These 4 Measures Indicate That Uniphar (ISE:UPR) Is Using Debt Reasonably Well
Nov 18The Returns At Uniphar (ISE:UPR) Aren't Growing
Sep 20Uniphar (ISE:UPR) Is Experiencing Growth In Returns On Capital
May 12The Uniphar plc (ISE:UPR) Full-Year Results Are Out And Analysts Have Published New Forecasts
Mar 03Estimating The Intrinsic Value Of Uniphar plc (ISE:UPR)
Dec 16Here's Why We Think Uniphar (ISE:UPR) Might Deserve Your Attention Today
Nov 24An Intrinsic Calculation For Uniphar plc (ISE:UPR) Suggests It's 45% Undervalued
Aug 01What Does Uniphar plc's (ISE:UPR) Share Price Indicate?
Jul 20Some Investors May Be Worried About Uniphar's (ISE:UPR) Returns On Capital
May 27An Intrinsic Calculation For Uniphar plc (ISE:UPR) Suggests It's 33% Undervalued
Apr 29Uniphar (ISE:UPR) Seems To Use Debt Quite Sensibly
Apr 02Here's Why I Think Uniphar (ISE:UPR) Might Deserve Your Attention Today
Mar 18Uniphar (ISE:UPR) Might Be Having Difficulty Using Its Capital Effectively
Feb 13Is Uniphar (ISE:UPR) A Risky Investment?
Dec 23Here's Why I Think Uniphar (ISE:UPR) Is An Interesting Stock
Oct 30Uniphar's (ISE:UPR) Returns On Capital Not Reflecting Well On The Business
May 14Uniphar (ISE:UPR) Has A Pretty Healthy Balance Sheet
Mar 10Does Uniphar's (ISE:UPR) Share Price Gain of 83% Match Its Business Performance?
Feb 23Will The ROCE Trend At Uniphar (ISE:UPR) Continue?
Feb 02Is Weakness In Uniphar plc (ISE:UPR) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Jan 15Trade Alert: The CEO & Executive Director Of Uniphar plc (ISE:UPR), Gerard Rabbette, Has Just Spent €900k Buying 4.2% More Shares
Dec 24Do Institutions Own Uniphar plc (ISE:UPR) Shares?
Dec 23Is Uniphar (ISE:UPR) Using Too Much Debt?
Dec 03Uniphar (ISE:UPR) Shareholders Have Enjoyed A 91% Share Price Gain
Nov 18Desglose de ingresos y gastos
Cómo gana y gasta dinero Uniphar. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
---|---|---|---|---|
31 Dec 23 | 2,553 | 45 | 313 | 0 |
30 Sep 23 | 2,436 | 45 | 294 | 0 |
30 Jun 23 | 2,318 | 45 | 276 | 0 |
31 Mar 23 | 2,195 | 45 | 257 | 0 |
31 Dec 22 | 2,071 | 46 | 237 | 0 |
30 Sep 22 | 2,020 | 47 | 232 | 0 |
30 Jun 22 | 1,970 | 49 | 226 | 0 |
31 Mar 22 | 1,957 | 48 | 222 | 0 |
31 Dec 21 | 1,943 | 48 | 217 | 0 |
30 Sep 21 | 1,930 | 39 | 206 | 0 |
30 Jun 21 | 1,917 | 30 | 195 | 0 |
31 Mar 21 | 1,871 | 29 | 183 | 0 |
31 Dec 20 | 1,824 | 28 | 171 | 0 |
30 Sep 20 | 1,780 | 26 | 164 | 0 |
30 Jun 20 | 1,736 | 25 | 158 | 0 |
31 Mar 20 | 1,701 | 23 | 149 | 0 |
31 Dec 19 | 1,665 | 21 | 141 | 0 |
30 Sep 19 | 1,607 | 20 | 130 | 0 |
30 Jun 19 | 1,549 | 19 | 119 | 0 |
31 Mar 19 | 1,484 | 14 | 105 | 0 |
31 Dec 18 | 1,418 | 9 | 92 | 0 |
31 Dec 17 | 1,265 | -2 | 83 | 0 |
31 Dec 16 | 1,294 | 5 | 79 | 0 |
31 Dec 15 | 1,117 | 6 | 60 | 0 |
31 Dec 14 | 1,129 | -19 | 68 | 0 |
31 Dec 13 | 860 | -18 | 39 | 0 |
Ingresos de calidad: UPR tiene ganancias de alta calidad.
Margen de beneficios creciente: Los actuales márgenes de beneficio(1.8%) de UPR son inferiores a los del año pasado (2.2%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: En los últimos 5 años, los beneficios de lUPR han crecido significativamente en un 23.4% al año.
Acelerando crecimiento: UPR ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.
Beneficios vs. Industria: UPR tuvo un crecimiento negativo de los beneficios (-1.7%) durante el año pasado, lo que dificulta la comparación con la media de la industria Healthcare (-0.8%).
Rentabilidad financiera
Alta ROE: La rentabilidad financiera de UPR (13.5%) se considera baja.